Document is current
Any future updates will be listed below
-
Authors
Pabba, Anirudh
Maetens, Marion
Mahdami, Amena
Geukens, Tatjana
De Schepper, Maxim
Zels, Gitte
Van Baelen, Karen
Leduc, Sophia
Nguyen, Ha Linh
Van Cauwenberge, Josephine
Borremans, Kristien
Hatse, Sigrid
Nysen, Madita
Rousseau, Emma
Di Tommaso, Angelica
Boeckx, Bram
Neven, Patrick
Wildiers, Hans
Biganzoli, Elia
Vermeulen, Peter
Van Den Bogaert, Wouter
Lambrechts, Diether
Floris, Giuseppe
Desmedt, Christine
Richard, François
-
Funding
Funding for this research was provided by:
KU Leuven (C14/21/114, C14/21/114, C14/21/114)
Fondation Cancer
European Research Council (FAT-BC 101003153, FAT-BC 101003153)
Fonds Wetenschappelijk Onderzoek (1S76522N, 1802222N, 1800125N, 1297322N)
Fund Nadine du beauffort
ASCO/Lobular Breast Cancer Alliance Young Investigator Award
Belgian Cancer Foundation (2020-103)
Klinische Onderzoeks- en Opleidingsraad (KOOR) of University Hospitals Leuven
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 3 September 2025
First Online: 6 November 2025
Competing interests
: H.W’s institution received financial compensation on his behalf for advisory boards, lecture fees and/or consultancy fees from Daiichi Sankyo, Gilead, Lilly, Pfizer, Novartis, PSI, Augustine Therapeutics, AstraZeneca, Roche, Agendia, Immutep, Seagen. He received travel support from Daiichi Sankyo. All remaining authors declare no financial or non-financial competing interests.
